Document Detail

Antithrombotic Drug Uses and Deep Intracerebral Hemorrhages in Stroke Patients with Deep Cerebral Microbleeds.
MedLine Citation:
PMID:  22959109     Owner:  NLM     Status:  Publisher    
BACKGROUND: It has been suggested that antiplatelet or anticoagulant drugs elevate the rate of intracerebral hemorrhage (ICH) in patients with cerebral microbleeds (MBs). To investigate the mechanism by which antiplatelet drugs or warfarin may contribute to deep ICH occurrences in patients with deep MBs, we prospectively analyzed deep ICH occurrences in 807 consecutive patients (351 females and 456 males; mean age ± standard deviation 69.8 ± 12.0 years) who were admitted to our hospital with strokes. METHODS: Occurrence-free rate curves were generated using the Kaplan-Meier method; deep ICH occurrence-free rates were compared using the log-rank test. The follow-up period was 0.5 to 71 months (mean ± standard deviation 31.6 ± 22.2 months). RESULTS: In patients with deep MBs, the rates (1.0%/year; 6 ICHs in 180 patients) of deep ICH occurrence associated with antiplatelet drugs were not significantly greater than that without the drugs (1.0%/year; 6 ICHs in 167 patients; P = .977). The incidence of deep ICHs associated with warfarin use was not significantly greater than that without warfarin use. CONCLUSIONS: Multivariate analysis revealed that the use of antiplatelet drugs or warfarin did not significantly influence the occurrence of deep ICH in patients with deep MBs. Antiplatelet drugs or warfarin did not significantly elevate the rate of deep ICHs in stroke patients with pre-existing deep MBs.
Toshio Imaizumi; Shigeru Inamura; Ikuhide Kohama; Kazuhisa Yoshifuji; Tatsufumi Nomura; Katsuya Komatsu
Related Documents :
24575739 - An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against hu...
22271809 - Drug-induced vasculitis: a clinical and pathological review.
15570189 - Midazolam therapeutic drug monitoring in intensive care sedation: a 5-year survey.
24250399 - The performance of loghman-hakim drug and poison information center from 2006 to 2008.
23391669 - Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: d...
23944929 - Drug-induced hepatotoxicity: incidence of abnormal liver function tests consistent with...
24575739 - An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against hu...
21680209 - Aggravation of absence seizure related to levetiracetam.
20029609 - Molecular modeling of swine influenza a/h1n1, spanish h1n1, and avian h5n1 flu n1 neura...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-9-6
Journal Detail:
Title:  Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association     Volume:  -     ISSN:  1532-8511     ISO Abbreviation:  J Stroke Cerebrovasc Dis     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-9-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9111633     Medline TA:  J Stroke Cerebrovasc Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Department of Neurosurgery, Kushiro City General Hospital, Hokkaido, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cerebral Infarction in both Carotid and Vertebrobasilar Territories Associated with a Persistent Pri...
Next Document:  Phase I Study of Intravenous Low-dose Granulocyte Colony-stimulating Factor in Acute and Subacute Is...